Amrize (NYSE:AMRZ) Rating Lowered to “Strong Sell” at Zacks Research

Amrize (NYSE:AMRZ) was downgraded by Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Wednesday,Zacks.com reports.

Several other brokerages have also issued reports on AMRZ. Morgan Stanley set a $63.00 price target on Amrize and gave the company an “overweight” rating in a research note on Monday, June 22nd. Citigroup reduced their price target on Amrize from $66.00 to $58.00 and set a “buy” rating on the stock in a research report on Tuesday, August 11th. Oppenheimer lowered their target price on shares of Amrize from $68.00 to $65.00 and set an “outperform” rating for the company in a research note on Tuesday, July 21st. Weiss Ratings upgraded shares of Amrize from a “sell (d+)” rating to a “hold (c)” rating in a research report on Thursday, August 13th. Finally, Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price target for the company in a report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $60.57.

Amrize Price Performance

AMRZ stock opened at $44.64 on Wednesday. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The stock has a market cap of $24.69 billion, a PE ratio of 20.57, a price-to-earnings-growth ratio of 1.07 and a beta of 0.11. Amrize has a 1 year low of $44.30 and a 1 year high of $65.94. The stock has a 50-day moving average price of $50.69 and a two-hundred day moving average price of $54.23.

Amrize (NYSE:AMRZ) last issued its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The firm had revenue of $3.50 billion during the quarter. Equities analysts forecast that Amrize will post 2.58 EPS for the current fiscal year.

Insider Buying and Selling at Amrize

In other news, insider Mario Gross bought 3,568 shares of Amrize stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the purchase, the insider directly owned 38,485 shares in the company, valued at $1,793,401. The trade was a 10.22% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CTO Roald Brouwer bought 1,500 shares of the stock in a transaction dated Tuesday, August 11th. The stock was purchased at an average price of $46.36 per share, with a total value of $69,540.00. Following the acquisition, the chief technology officer owned 21,490 shares of the company’s stock, valued at $996,276.40. The trade was a 7.50% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders purchased 14,828 shares of company stock worth $697,479. 0.54% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Amrize

A number of institutional investors have recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Amrize in the fourth quarter valued at approximately $929,333,000. Harris Associates L P purchased a new position in Amrize in the fourth quarter worth $615,406,000. Wellington Management Group LLP increased its position in shares of Amrize by 48.8% during the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after purchasing an additional 3,809,133 shares during the last quarter. Marshall Wace LLP raised its stake in shares of Amrize by 865.4% during the 3rd quarter. Marshall Wace LLP now owns 2,889,660 shares of the company’s stock worth $139,436,000 after purchasing an additional 2,590,336 shares during the period. Finally, Barclays PLC raised its stake in shares of Amrize by 95.4% during the 4th quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock worth $249,557,000 after purchasing an additional 2,253,431 shares during the period.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.